Adaptive Biotechnologies Corp’s recent filing unveils that its Chief People Officer LO FRANCIS unloaded Company’s shares for reported $1.41 million on Jan 12 ’26. In the deal valued at $17.73 per share,79,590 shares were sold. As a result of this transaction, LO FRANCIS now holds 315,978 shares worth roughly $5.54 million.
Then, PISKEL KYLE sold 4,290 shares, generating $77,220 in total proceeds. Upon selling the shares at $18.00, the Chief Financial Officer now owns 216,637 shares.
Before that, FRANCIS LO bought 64,293 shares. Adaptive Biotechnologies Corp shares valued at $1,013,258 were divested by the Officer at a price of $15.76 per share.
A number of analysts have revised their coverage, including Guggenheim’s analysts, who began to cover the stock in late September with a ‘”a Buy”‘ rating. Craig Hallum began covering ADPT with “Buy” recommendation on June 18, 2025. Goldman revised its rating on March 21, 2025. It rated ADPT as “a Buy” which previously was an “a Neutral”.
Price Performance Review of ADPT
On Friday, Adaptive Biotechnologies Corp [NASDAQ:ADPT] saw its stock fall -1.46% to $17.52. Over the last five days, the stock has gained 11.17%. Adaptive Biotechnologies Corp shares have risen nearly 144.69% since the year began. Nevertheless, the stocks have risen 7.88% over the past one year.
How much short interest is there in Adaptive Biotechnologies Corp?
A steep rise in short interest was recorded in Adaptive Biotechnologies Corp stocks on 2025-12-31, dropping by -1.64 million shares to a total of 8.76 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-28 was 10.4 million shares. There was a decline of -18.76%, which implies that there is a negative sentiment for the stock.
